Reporting the counterparty's growth as its own: management explains the company's coming year by narrating what its cust
The model's full reasoning — Q3 2021 call → NOThe question asks whether management explains the company's business direction by narrating what its counterparties are themselves doing and scaling. Let me analyze the transcript carefully. The company is Alignment Healthcare, a Medicare Advantage plan operator. The "counterparties" in this context would be... well, they're a health plan, so their counterparties would be members, providers, or partners. Looking at the transcript, management discusses: - Their AVA platform and clinical model - Their own growth and membership - Their partnerships with health systems (Cedars-Sinai, Scripps, Hoag) for PPO products - Their DCE (Direct Contracting Entity) program with CMS - Their Star Ratings But the question is specifically about whether management narrates what counterparties are doing and scaling as the driver of the company's own growth. Let me look for this pattern. Management talks about: 1. Their own AVA platform improvements 2. Their own clinical model 3. Their own membership growth 4. Their own product launches 5. Their DCE program with CMS - but here they're the operator, not supplying someone else The company is a health plan - they're the payer/operator. Their "counterparties" would be providers, health systems, or members. But the forward account is about their own growth, their own products, their own AEP (Annual Election Period) performance, their own market expansion. When they mention partnerships with Cedars-Sinai, Scripps, and Hoag - these are for launching PPO products, but they don't narrate those health systems' own expansion trajectories as the driver of Alignment's growth. They just mention the partnerships exist. The DCE program - they're participating in a CMS program, but they don't describe CMS's own trajectory as driving their growth. They're evaluating the program's profitability. The forward account is about: - Their own AEP performance - Their own product launches - Their own market expansion - Their own investments in growth Management explains their outlook through their own actions - new products, selling effort, marketing, market expansion. They don't narrate identifiable counterparties' own trajectories as the driver of their coming activity. The answer is NO.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| EMKR | EMCORE Corporation | Q4 2023 | 2023-12-12 | C+ |
| MBLY | Mobileye Global Inc. | Q2 2023 | 2023-07-28 | B+ |
| PI | Impinj, Inc. | Q4 2022 | 2023-02-08 | B+ |
| FAT | FAT Brands Inc. | Q4 2021 | 2022-03-21 | F |
| OOMA | Ooma, Inc. | Q3 2022 | 2021-12-02 | B+ |
| ILMN | Illumina, Inc. | Q1 2018 | 2018-04-24 | A |
| PLAB | Photronics, Inc. | Q2 2017 | 2017-05-17 | C+ |
| IONS | Ionis Pharmaceuticals, Inc. | Q1 2017 | 2017-05-09 | C |
| FNV | Franco-Nevada Corporation | Q3 2016 | 2016-11-08 | B+ |
| HXL | Hexcel Corporation | Q4 2015 | 2016-01-22 | B+ |
OOMA · Q3 2022 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future volume as a consequence of those parties' trajectories.
MBLY · Q2 2023 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's volume as a consequence of those parties' trajectories.
ILMN · Q1 2018 → YESThe question is about whether management narrates what its counterparties are doing and scaling, presenting the company's future as a consequence of those parties' trajectories.